mRNA Combo Shows Promise Against Melanoma | Science News

Merck and Moderna just dropped a game-changing update on melanoma treatment: their combo of Keytruda and a custom mRNA therapy is showing landmark results in stopping cancer recurrence and boosting survival rates. This mRNA tech works by teaching your immune system to target your tumor’s unique genetic fingerprint — like giving your body a personalized cancer hit list. While full FDA approval still awaits, early data from phase three trials is electrifying, especially for advanced melanoma where survival plummets once it spreads. More studies are underway to see if this powerful duo can extend lives — and reshape how we fight skin cancer forever. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/f7e1ff95886bed45